Complete Filing Data
Keen Vision Acquisition Corp. reported Stockholders Equity of -$7.01 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Keen Vision Acquisition Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income Loss | $1.9M | $7.4M | $1.5M | -$693.00 |
| Comprehensive Income Net Of Tax | $1.9M | $5.9M | $3.0M | -$693.00 |
| Nonoperating Income Expense | $2.7M | $8.9M | $1.9M | $4.00 |
| Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax | ||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Before Tax | $1.5M | |||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $1.5M | |||
| Other Comprehensive Income Realized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | $373.5K | $558.1K | $568.2K | $1.6M | $1.8M | $3.3M | -$305.7K | -$845.00 | -$4.0K | -$218.00 | $1.00 | -$176.00 |
| Comprehensive Income Net Of Tax | $373.5K | $558.1K | $568.2K | $1.6M | $1.8M | $1.7M | $1.1M | -$845.00 | -$4.0K | -$218.00 | ||
| Nonoperating Income Expense | $621.9K | $750.1K | $739.5K | $2.1M | $2.0M | $3.5M | $19.00 | $1.00 | $2.00 | |||
| Other Comprehensive Income Reclassification Adjustment For Held To Maturity Transferred To Available For Sale Securities Before Tax | -$1.5M | $1.4M | ||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Before Tax | $1.5M | |||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | $1.4M | |||||||||||
| Other Comprehensive Income Realized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$1.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$7.0M | -$4.2M | -$2.1M | $21.2K | $21.9K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $11.2K | $54.5K | $631.8K | $77.7K | $24.9K |
| Temporary Equity Accretion To Redemption Value | $4.7M | $7.9M | $13.5M | ||
| Retained Earnings Accumulated Deficit | -$7.0M | -$4.2M | -$3.7M | -$3.8K | |
| Liabilities And Stockholders Equity | $57.0M | $70.4M | $155.7M | $194.8K | |
| Liabilities | $7.0M | $4.3M | $3.0M | $173.6K | |
| Common Stock Value | $442.00 | $442.00 | $442.00 | $374.00 | |
| Assets Current | $36.8K | $63.8K | $865.6K | $80.3K | |
| Assets | $57.0M | $70.4M | $155.7M | $194.8K | |
| Liabilities Current | $4.1M | $1.3M | $14.0K | $173.6K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$43.3K | -$577.2K | $554.0K | $52.8K | |
| Temporary Equity Carrying Amount Attributable To Parent | $57.0M | $70.4M | $154.8M | ||
| Accrued Liabilities Current | $73.5K | $97.8K | $4.0K | ||
| Deferred Compensation Liability Classified Noncurrent | $3.0M | $3.0M | $3.0M | ||
| Assets Held In Trust Noncurrent | $57.0M | $70.4M | $154.8M | ||
| Accrued Underwriting Compensations | $4.7M | $7.9M | $3.0M | ||
| Other Notes Payable Current | $2.7M | $600.0K | |||
| Cash And Cash Equivalents At Carrying Value | $11.2K | $54.5K | $631.8K | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.5M | ||||
| Temporary Equity Accretion To Redemption Value Adjustment | -$13.5M | ||||
| Repayments Of Related Party Debt | $367.5K | ||||
| Cash | $11.2K | $54.5K | $631.8K | ||
| Assets Held In Trust | |||||
| Deferred Costs | $114.5K | ||||
| Cash Withdrawn From Trust Account In Connection To Redemption | $18.1M | $92.4M | |||
| Transfer To Realized Gain In Investments Held In Trust Account | -$1.5M | $1.5M | |||
| Accrued Underwriting Compensation | $3.0M | ||||
| Notes Payable Current | |||||
| Initial Classification Of Common Stock Subject To Possible Redemption | $147.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$6.4M | -$5.8M | -$5.0M | -$3.2M | -$2.7M | -$2.4M | -$2.0M | $16.4K | $17.2K | $21.5K | $21.8K | $21.8K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.9K | $1.3K | $16.0K | $40.5K | $261.4K | $478.6K | $735.4K | $4.7K | $1.5K | $12.0K | $72.2K | |||
| Temporary Equity Accretion To Redemption Value | $1.1M | $1.4M | $1.3M | $2.1M | $2.0M | $2.0M | $11.4M | |||||||
| Retained Earnings Accumulated Deficit | -$6.4M | -$5.8M | -$5.0M | -$3.2M | -$2.7M | -$2.4M | -$3.4M | -$8.6K | ||||||
| Liabilities And Stockholders Equity | $56.0M | $73.1M | $71.8M | $161.0M | $159.2M | $157.5M | $153.8M | $295.2K | ||||||
| Liabilities | $6.5M | $5.8M | $5.1M | $3.2M | $3.0M | $3.0M | $3.0M | $278.9K | ||||||
| Common Stock Value | $442.00 | $442.00 | $442.00 | $442.00 | $442.00 | $442.00 | $442.00 | $374.00 | ||||||
| Assets Current | $18.7K | $65.1K | $88.1K | $43.0K | $334.9K | $628.1K | $1.0M | $5.1K | ||||||
| Assets | $56.0M | $73.1M | $71.8M | $161.0M | $159.2M | $157.5M | $153.8M | $295.2K | ||||||
| Liabilities Current | $3.5M | $2.8M | $2.1M | $230.8K | $17.0K | $42.9K | $30.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$38.6K | -$153.2K | -$76.2K | |||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $56.0M | $73.1M | $71.7M | $160.9M | $158.9M | $156.8M | $152.8M | |||||||
| Accrued Liabilities Current | $38.7K | $28.9K | $23.8K | $130.8K | $7.0K | $32.9K | ||||||||
| Deferred Compensation Liability Classified Noncurrent | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | ||||||||
| Assets Held In Trust Noncurrent | $56.0M | $73.1M | $71.7M | $160.9M | $158.9M | |||||||||
| Accrued Underwriting Compensations | $1.3M | $2.0M | ||||||||||||
| Other Notes Payable Current | $2.2M | $1.8M | $1.2M | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $16.0K | |||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.4M | |||||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | -$2.0M | -$147.9M | ||||||||||||
| Repayments Of Related Party Debt | ||||||||||||||
| Cash | $16.0K | |||||||||||||
| Assets Held In Trust | $156.8M | $154.8M | $152.8M | |||||||||||
| Deferred Costs | $290.1K | |||||||||||||
| Cash Withdrawn From Trust Account In Connection To Redemption | ||||||||||||||
| Transfer To Realized Gain In Investments Held In Trust Account | -$1.5M | |||||||||||||
| Accrued Underwriting Compensation | $2.0M | |||||||||||||
| Notes Payable Current | $278.9K | $173.6K | ||||||||||||
| Initial Classification Of Common Stock Subject To Possible Redemption |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$784.1K | -$1.1M | -$705.9K | -$3.3K |
| Increase Decrease In Prepaid Expense | $16.3K | -$224.6K | $231.3K | $2.6K |
| Net Cash Provided By Used In Financing Activities | -$15.3M | -$91.2M | $152.6M | $56.1K |
| Proceeds From Related Party Debt | $740.8K | $565.1K | $318.4K | $56.1K |
| Increase Decrease In Accrued Liabilities | -$24.3K | $93.8K | $4.0K | |
| Net Cash Provided By Used In Investing Activities | $16.0M | $91.8M | -$151.4M | |
| Payments To Acquire Investments | $2.1M | $600.0K | ||
| Proceeds From Notes Payable | $2.1M | $600.0K | ||
| Proceeds From Issuance Of Private Placement | $6.8M | |||
| Proceeds From Issuance Initial Public Offering | $149.5M | |||
| Payments Of Stock Issuance Costs | $3.6M | |||
| Payments For Repurchase Of Common Stock | $18.1M | $92.4M | ||
| Payments Of Debt Issuance Costs | $3.6M | |||
| Proceeds From Repayments Of Related Party Debt | $318.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$308.2K | -$153.2K | -$2.1K |
| Increase Decrease In Prepaid Expense | $62.9K | -$84.4K | -$2.0K |
| Net Cash Provided By Used In Financing Activities | $869.6K | -$74.2K | |
| Proceeds From Related Party Debt | $269.6K | $70.3K | |
| Increase Decrease In Accrued Liabilities | -$74.0K | $28.9K | |
| Net Cash Provided By Used In Investing Activities | -$600.0K | ||
| Payments To Acquire Investments | $600.0K | ||
| Proceeds From Notes Payable | $600.0K | ||
| Proceeds From Issuance Of Private Placement | |||
| Proceeds From Issuance Initial Public Offering | |||
| Payments Of Stock Issuance Costs | $144.5K | ||
| Payments For Repurchase Of Common Stock | |||
| Payments Of Debt Issuance Costs | |||
| Proceeds From Repayments Of Related Party Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Common Stock Shares Outstanding | 4.4M | 4.4M | 4.4M | 3.7M |
| Common Stock Shares Issued | 4.4M | 4.4M | 4.4M | 3.7M |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Temporary Equity Shares Outstanding | 4.8M | 15.0M | 15.0M | 0.00 |
| Temporary Equity Shares Issued | 4.8M | 15.0M | 15.0M | 0.00 |
| Weighted Average Number Of Shares Outstanding Basic | ||||
| Weighted Average Number Of Diluted Shares Outstanding | ||||
| Earnings Per Share Diluted | ||||
| Earnings Per Share Basic | ||||
| Temporary Equity Shares Authorized | 500.0M | 500.0M | ||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 3.7M | 4.4M | |
| Common Stock Shares Issued | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 4.4M | 3.7M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Temporary Equity Shares Outstanding | 4.8M | 6.4M | 6.4M | 15.0M | 15.0M | 15.0M | ||||
| Temporary Equity Shares Issued | 4.8M | 6.4M | 6.4M | 15.0M | 15.0M | 15.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 3.3M | 3.3M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 3.3M | 3.3M | ||||||||
| Earnings Per Share Diluted | $0.00 | $0.00 | ||||||||
| Earnings Per Share Basic | $0.00 | $0.00 | ||||||||
| Temporary Equity Shares Authorized | ||||||||||
| Temporary Equity Par Or Stated Value Per Share |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating Costs And Expenses | $743.5K | $1.5M | $478.7K | $697.00 | |
| Prepaid Expense Current | $25.6K | $9.2K | $233.9K | $2.6K | |
| Investment Income Dividend | $2.7M | $6.8M | $2.00 | ||
| Interest Income Other | $1.00 | $26.00 | $37.00 | ||
| Investment Income Interest | $2.0M | $1.9M | $4.00 | ||
| Interest And Other Income | |||||
| Direct Operating Costs | |||||
| Unrealized Gain Loss On Hybrid Instrument Net | $1.5M | ||||
| Stock Issued During Period Value New Issues | $142.9M | $25.0K | |||
| Due From Banks | $77.7K | ||||
| Stock Issued During Period Value Other | $6.8M | ||||
| Proceeds Deposited In Trust Account | $151.4M | ||||
| Investment Income Interest And Dividend | $2.00 | ||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $6.5M | ||||
| Accretion Of Carrying Value To Redemption Value | $13.5M | ||||
| Stock Redeemed Or Called During Period Value | $147.9M | ||||
| Stock Issued During Period Value Transfer To Realized Gain On Available Held For Sale Securities | -$1.5M | ||||
| Stock Issued1 | $6.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $248.5K | $192.0K | $171.3K | $505.7K | $267.3K | $266.4K | $305.7K | $845.00 | $4.0K | |||
| Prepaid Expense Current | $2.8K | $63.8K | $72.1K | $2.5K | $73.5K | $149.5K | $314.3K | $425.00 | ||||
| Investment Income Dividend | $621.9K | $750.1K | $739.5K | $2.1M | $2.0M | $1.5M | $1.00 | |||||
| Interest Income Other | $1.00 | $3.00 | $8.00 | $14.00 | $18.00 | |||||||
| Investment Income Interest | $2.0M | $1.00 | ||||||||||
| Interest And Other Income | $18.00 | $2.00 | $1.00 | |||||||||
| Direct Operating Costs | $305.7K | $845.00 | $220.00 | |||||||||
| Unrealized Gain Loss On Hybrid Instrument Net | -$1.5M | $1.4M | ||||||||||
| Stock Issued During Period Value New Issues | $142.9M | |||||||||||
| Due From Banks | $478.6K | $631.8K | ||||||||||
| Stock Issued During Period Value Other | $6.8M | |||||||||||
| Proceeds Deposited In Trust Account | $1.5M | |||||||||||
| Investment Income Interest And Dividend | $1.00 | |||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $6.5M | |||||||||||
| Accretion Of Carrying Value To Redemption Value | $11.4M | |||||||||||
| Stock Redeemed Or Called During Period Value | $147.9M | |||||||||||
| Stock Issued During Period Value Transfer To Realized Gain On Available Held For Sale Securities | ||||||||||||
| Stock Issued1 |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.